BEONE MEDICINES LTD. (ONC)

Every figure this model derived for ONC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 153,871,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 5,100,641,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 7,215,805,000 AssetsCurrent 2026-06-30
current liabilities 2,119,187,000 LiabilitiesCurrent 2026-06-30
equity 5,173,998,000 StockholdersEquity 2026-06-30
interest expense 36,730,000 InterestPaidNet 2026-06-30
ocf 1,484,056,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 6,128,963,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 525,330,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ONC on one particular measure came for.

RatioValue
cash operating margin26.16
current ratio3.4
current ratio reported3.4
deferred revenue growth-100.0
dilution pct7.76
fcf margin21.7
growth cv1.01
interest cover25.13
operating margin15.06
owner earnings margin13.13
revenue growth34.35
revenue growth per share24.68
roic69.26
rule of 4049.41
sbc pct revenue8.57

What to be careful about

What this model itself distrusts about ONC's figures. Written by the derivation as it ran, not added afterwards.